Clinical Trials for Neuroblastoma

Find clinical trials for neuroblastoma. Discover research opportunities and treatment options in your area.

78 Active Trials Found

Showing 78 trials on this page

Page 3 of 4

A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

NCT ID: NCT03966651

This clinical trial is studying a treatment called Peptide Receptor Radionuclide Therapy (PRRT) using a specific drug, 177Lu-DOTATATE, for children with a type of cancer called neuroblastoma that h...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nancy, , France, Nantes, , France +11 more

International PPB/DICER1 Registry

NCT ID: NCT03382158

The International PPB/DICER1 Registry is a study aimed at understanding rare childhood tumors and conditions associated with the DICER1 gene. It focuses on pleuropulmonary blastoma (PPB), a type of...

Recruiting

Type: observational Locations: Minneapolis, Minnesota, United States

Interest of Preoperative Arteriography to Identify the Adamkiewicz Artery Before Surgery for Basi-thoracic Neuroblastic Tumors

NCT ID: NCT06798532

This clinical trial is studying whether using a special imaging test called arteriography before surgery can help identify a critical blood vessel, known as the Adamkiewicz artery, in patients with...

Not yet recruiting

Type: observational Locations: Caen, , France, Grenoble, , France +25 more

Biomarkers of Resiliency in Childhood Cancer Surgery

NCT ID: NCT06674811

This clinical trial, called "Biomarkers of Resiliency in Childhood Cancer Surgery," is focused on understanding how children and their families recover after major surgery for cancer. The researche...

Recruiting

Type: observational Locations: Rochester, Minnesota, United States

A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma

NCT ID: NCT06684639

This clinical trial is exploring a new treatment for neuroblastoma, a type of cancer that affects the nervous system, particularly in children. The study is testing a special therapy called GD2-CAR...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Chengdu, Sichuan, China

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

NCT ID: NCT04337177

This clinical trial is studying a new flavored oral medication called irinotecan VAL-413 (Orotecan®) combined with another drug called temozolomide to treat children and young adults with certain t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Cincinnati, Ohio, United States, Nashville, Tennessee, United States +7 more

18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma

NCT ID: NCT05826158

This clinical trial is studying a new imaging technique called 18F-mFBG PET/CT to see how well it works compared to an existing method called 123I-mIBG scintigraphy for evaluating children with neu...

Recruiting

Phase: NA Type: interventional Locations: Copenhagen, , Denmark

GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children with Neuroblastoma

NCT ID: NCT03294954

This clinical trial is studying a new treatment for children with a type of cancer called neuroblastoma. The research combines two approaches: using special proteins called antibodies that target c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

9-ING-41 in Pediatric Patients with Refractory Malignancies.

NCT ID: NCT04239092

This clinical trial is studying a new treatment called 9-ING-41 for children and young adults under 22 years old who have certain types of hard-to-treat cancers, known as refractory malignancies. T...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Ann Arbor, Michigan, United States +7 more

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

NCT ID: NCT02508038

This clinical trial is looking at a new way to treat children with certain types of blood cancers (like leukemia and lymphoma) and high-risk solid tumors (like neuroblastoma and osteosarcoma). The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Madison, Wisconsin, United States

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT ID: NCT04851119

This clinical trial is studying a new medication called tegavivint, which is being tested to see if it can help patients with certain types of solid tumors that have either come back after treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Saint Louis, Missouri, United States +20 more

Neuroblastoma Maintenance Therapy Trial

NCT ID: NCT02679144

The Neuroblastoma Maintenance Therapy Trial is a study looking at a medication called difluoromethylornithine (DFMO) to help prevent the return of neuroblastoma in children and young adults who are...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Milwaukee, Wisconsin, United States +52 more

Neuroblastoma Biology Study

NCT ID: NCT01587300

The Neuroblastoma Biology Study is a clinical trial aimed at understanding more about neuroblastoma, a type of cancer that mostly affects young children. The researchers are looking to learn how ne...

Recruiting

Type: observational Locations: Philadelphia, Pennsylvania, United States, Los Angeles, California, United States +18 more

Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma

NCT ID: NCT06574698

This clinical trial is studying the effects of adding a treatment called Naxitamab, which targets a specific protein found on neuroblastoma cells, to the standard chemotherapy for children with hig...

Recruiting

Type: observational Locations: Guanzhou, Guangdong, China

68Ga-DOTATATE Neuroblastoma Imaging Pilot

NCT ID: NCT04559217

The 68Ga-DOTATATE Neuroblastoma Imaging Pilot is a clinical trial designed to explore a new imaging method for diagnosing and monitoring neuroblastoma, a type of cancer that primarily affects young...

Recruiting

Phase: PHASE2 Type: interventional Locations: Sherbrooke, Quebec, Canada, Montréal, Quebec, Canada +1 more

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

NCT ID: NCT02559778

The Pediatric Precision Laboratory Advanced Neuroblastoma Therapy trial is studying a new way to treat high-risk neuroblastoma, a type of cancer commonly found in children. This clinical trial is l...

Recruiting

Phase: PHASE2 Type: interventional Locations: Charleston, South Carolina, United States, Phoenix, Arizona, United States +26 more

Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma

NCT ID: NCT04301843

This clinical trial is studying the combination of two drugs, Eflornithine (also known as DFMO) and Etoposide, to see if they can help patients with neuroblastoma that has come back or has not resp...

Recruiting

Phase: PHASE2 Type: interventional Locations: Milwaukee, Wisconsin, United States, Charleston, South Carolina, United States +30 more

Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

NCT ID: NCT02605421

This clinical trial is looking at a treatment approach for children and young adults with high-risk neuroblastoma, a type of cancer that affects the nervous system. The study involves giving two ro...

Recruiting

Phase: PHASE2 Type: interventional Locations: Minneapolis, Minnesota, United States

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

NCT ID: NCT05400603

This clinical trial is looking at a new treatment approach for children with hard-to-treat cancers called neuroblastoma or osteosarcoma. Specifically, the study will test a type of immune cell ther...

Recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States

Identification of New Gene Spliceosomes in Neuroblastoma

NCT ID: NCT06502210

This clinical trial is focused on studying neuroblastoma, a type of cancer that mostly affects young children. The goal is to better understand the genetic differences in neuroblastoma by analyzing...

Recruiting

Type: observational Locations: Nantong, Jiangsu, China, Nantong, Jiangsu, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions